Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years, NY Consulting Firm Predicts
Portfolio Pulse from Lara Goldstein
NY-based consulting firm Research Nester predicts the global market for psychedelic substances will grow at a CAGR of around 14% over the next 12 years, reaching $12 billion by 2035. The report features key players such as COMPASS Pathways, Silo Pharma, Numinus Wellness, Cybin, Mind Medicine, PharmaTher Holdings, atai Life Sciences, Jazz Pharmaceuticals, Janssen Pharmaceuticals, and Pfizer. The growth is attributed to increased demand for psychedelic drugs to treat mental health issues, reduced production costs due to the pandemic, and increased investment in R&D.
September 12, 2023 | 8:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
atai Life Sciences is identified as a key player in the growing psychedelic drugs market, which is expected to reach $12 billion by 2035.
The company's mention as a key player in the growing market indicates potential growth opportunities. The predicted market growth could lead to increased revenues for the company, positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
COMPASS Pathways is identified as a key player in the growing psychedelic drugs market, which is expected to reach $12 billion by 2035.
The company's mention as a key player in the growing market indicates potential growth opportunities. The predicted market growth could lead to increased revenues for the company, positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Cybin is identified as a key player in the growing psychedelic drugs market, which is expected to reach $12 billion by 2035.
The company's mention as a key player in the growing market indicates potential growth opportunities. The predicted market growth could lead to increased revenues for the company, positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jazz Pharmaceuticals is identified as a key player in the growing psychedelic drugs market, which is expected to reach $12 billion by 2035.
The company's mention as a key player in the growing market indicates potential growth opportunities. The predicted market growth could lead to increased revenues for the company, positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Janssen Pharmaceuticals is identified as a key player in the growing psychedelic drugs market, which is expected to reach $12 billion by 2035.
The company's mention as a key player in the growing market indicates potential growth opportunities. The predicted market growth could lead to increased revenues for the company, positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Mind Medicine is identified as a key player in the growing psychedelic drugs market, which is expected to reach $12 billion by 2035.
The company's mention as a key player in the growing market indicates potential growth opportunities. The predicted market growth could lead to increased revenues for the company, positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Numinus Wellness is identified as a key player in the growing psychedelic drugs market, which is expected to reach $12 billion by 2035.
The company's mention as a key player in the growing market indicates potential growth opportunities. The predicted market growth could lead to increased revenues for the company, positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Pfizer is identified as a key player in the growing psychedelic drugs market, which is expected to reach $12 billion by 2035.
The company's mention as a key player in the growing market indicates potential growth opportunities. The predicted market growth could lead to increased revenues for the company, positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
PharmaTher Holdings is identified as a key player in the growing psychedelic drugs market, which is expected to reach $12 billion by 2035.
The company's mention as a key player in the growing market indicates potential growth opportunities. The predicted market growth could lead to increased revenues for the company, positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Silo Pharma is identified as a key player in the growing psychedelic drugs market, which is expected to reach $12 billion by 2035.
The company's mention as a key player in the growing market indicates potential growth opportunities. The predicted market growth could lead to increased revenues for the company, positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80